SEC Cover Up Destroys LPHI Shareholders
LPHI Shareholders
SEC Cover Up Destroys LPHI Shareholders
LPHI Shareholders Lose $480 Million
Today, Life Partners Holdings announced that U.S. Senior Federal Judge James Knowlin
ruled in favor of Life Partners and its officers, Brian Pardo & Scott Peden, that NO FRAUD
WHATSOEVER was committed on any of the bogus allegations alleged by the SEC. The
favorable ruling of the issues relating to revenue recognition (which has given the SEC a
HUGE DEFEAT) gave Life Partners a clean sweep win over the SEC in what amounted to an
important case for the SEC. This is the 2nd time in 23 years Life Partners has taken the SEC
all the way to trial, and embarrassed the SEC with unanimous clean sweeps! There are a lot
of reporters, namely the Wall Street Journal and the Communications Director from the SEC
eating a lot of crow this morning after issuing a misleading headline claiming victory back in
early February knowing the SEC had not presented any evidence on these baseless charges.
Now, a year-long investigation reveals shocking evidence that the SEC covered up the truth related to the real cause of LPHI’s stock plummeting from $30/share to $2/share. This deception cost shareholders an astounding 480 million dollars.
Rather than protect shareholders, the SEC initiated a phony investigation into LPHI which lasted over 3 years and cost the company millions in legal fees and loss of credibility for that length of time.
Brian Pardo and the LPHI Board of Directors had to defend the case all the way to a jury trial because they knew the company was innocent. At trial the SEC did not produce a single piece of evidence to substantiate the bogus charges they fabricated. This fabrication was a diversion from what the SEC knew was the real cause of the shareholder losses. They hid this for more than 3 years until indisputable evidence finally surfaced that proved the shareholder loss was caused by illegal short selling by Options Express, a subsidiary of Charles Schwab, and other major Wall Street firms!
The SEC thought they could drag the investigation out long enough to force LPHI to go out of business. When that did not happen, the SEC was in the precarious position of being forced to go to trial with Brian Pardo, knowing they had no evidence! Their only prayer was that by some miracle they could dupe the jury with complicated lingo and a so-called expert from New Jersey into believing LPHI and Brian Pardo had committed securities fraud by causing the company to understate projected life expectancies of senior policy holders.
A jury of eight hard-working citizens from the Austin, Texas, area saw through the smoke and mirrors of complicated legal drivel the SEC tried to use. Elizabeth Yingling, lead LPHI attorney with Baker McKenzie, presented the case very simply so the jury understood the life
KMA Global Solutions International, Inc. (KMAG) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Top 5 Most Recently Viewed Articles
Ascot Resources Reports First Quarter Financial Insights Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) is excited to share its financial results for the three months ended March 31, 2025. The company has made significant strides in enhancing its operational framework and improving profitability while facing industry dynamics. This report outlines key highlights and...
Continue Reading
Why New York CEOs Should Consider Florida for Business Growth As economic conditions fluctuate, business leaders are often faced with challenging decisions that can impact their companies significantly. In light of this uncertainty, the Florida Council of 100 has taken a proactive approach by reaching out to business executives in New York, encouraging them to explore the...
Continue Reading
Exploring Advanced Monoclonality Assurance Techniques In today’s cutting-edge biomedical landscape, ensuring monoclonality in cell line development is crucial for the stability of protein, cellular, and gene therapies. Join us in a fascinating opportunity to gain insights into improving monoclonality assurance at our upcoming webinar. Webinar Overview and Key Benefits...
Continue Reading
Current Trends in Cryptocurrency Trading The world of cryptocurrency is experiencing a significant uptick, with Bitcoin currently trading above $113,000. This exciting momentum is drawing attention as major players like Ethereum and XRP also show positive movements. Price Highlights As of the latest updates, Bitcoin is priced at an impressive $113,651.45. Ethereum follows...
Continue Reading
Havila Kystruten AS Announces Reverse Share Split Today marks an important milestone for Havila Kystruten AS as the company implements a reverse share split. This action is part of their ongoing strategic initiatives to strengthen their position in the market. Overview of the Reverse Share Split The reverse share split will alter the number of shares available for...
Continue Reading